CD40LG and Alzheimer disease: In fact, blocking CD40-CD154 interactions by a neutralizing antibody strategy prevents murine experimental autoimmune encephalomyelitis (EAE) disease activity [16-19] as well as AD-like pathology in mouse models of the disease [20].